k.dahlberg
TL2 Moderator · Cali
Contributes reviews on supplier material. Based in Cali.
Joined 8 November 2024 · last posted 18h
83 posts, newest first. Showing up to 150.
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #24 · Practice › Side effects · 27 Jul 2026 · 0 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Historical amylin analogues and what happened to them Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 27 Jul 2026 · 0 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Seven-day rolling means and why weekly readings mislead Replied, post #95 · Outcomes › Progress reports · 24 Jul 2026 · 9 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Journal club: what we got wrong in an earlier session Replied, post #108 · Evidence › Journal club · 22 Jul 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Seven-day rolling means and why weekly readings mislead Replied, post #76 · Outcomes › Progress reports · 21 Jul 2026 · 10 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #15 · Analytics › COA interpretation · 16 Jul 2026 · 0 likes Worth separating two things that post #11 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #25 · Sourcing › Vendor reports · 13 Jul 2026 · 1 like This follows post #22 rather than contradicting it. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a…
-
Which categories are strict and which are relaxed, honestly Replied, post #7 · marked as the solution · Start Here › Welcome · 11 Jul 2026 · 14 likes I read post #5 twice before replying, because I had assumed the opposite. Welcome. The orientation materials are pinned at the top of this category and they take about…
-
Prescription requirements and telehealth models — a second dataset Replied, post #74 · Sourcing › Regulatory · 21 Jun 2026 · 3 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #75 · Devices › Syringes & needles · 17 Jun 2026 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #96 · Outcomes › Body composition · 16 Jun 2026 · 0 likes post #95 answers the question as asked. The question underneath it is different. Comparison to published data: the trials reported mean fat and lean mass changes.…
-
Publication patterns in the BPC-157 literature, examined Replied, post #7 · Compounds › Repair & healing peptides · 3 Jun 2026 · 32 likes Picking up post #4: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Revisiting: The best-written scientific paper you have read Replied, post #12 · Lounge › Off topic · 2 Jun 2026 · 11 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
Private prescribing in the UK: what is actually involved Replied, post #20 · Regional › UK & Ireland · 21 May 2026 · 20 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
CJC-1295 with and without DAC: what the modification does Replied, post #61 · Compounds › Secretagogues & GH axis · 19 May 2026 · 0 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Moderation log format change Replied, post #53 · Meta › Announcements · 15 May 2026 · 19 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #44 · Evidence › Journal club · 10 May 2026 · 1 like On post #40 — agreed on the reasoning, with one qualification. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
Historical amylin analogues and what happened to them Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 7 May 2026 · 31 likes On post #2 — agreed on the reasoning, with one qualification. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #23 · Analytics › Home & field testing · 6 May 2026 · 22 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #22 · Practice › Reconstitution · 22 Apr 2026 · 1 like Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Why the timeline is on the right and not the left — what changed since Replied, post #23 · Meta › Site feedback · 20 Apr 2026 · 14 likes Coming back to post #21, because the follow-up matters more than the original answer. Community norms: if you think a norm has drifted or is not being followed…
-
Spike-and-recover accuracy for a peptide assay Replied, post #30 · Analytics › Method validation · 7 Apr 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #28 · Lounge › Introductions · 10 Mar 2026 · 9 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #5 · Clinical › Comorbidities · 9 Mar 2026 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 1 like Coming back to post #38, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #102 · Access › Pricing · 28 Feb 2026 · 6 likes Worth separating two things that post #98 runs together. Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #133 · Practice › Dosing & titration · 22 Feb 2026 · 0 likes I read post #131 twice before replying, because I had assumed the opposite. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #38 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes post #37 is right about the mechanism and I think understates the practical bit. Mass accuracy is expressed in parts per million. It is the difference between observed…
-
Trifluoroacetate content and its consequences Replied, post #81 · Analytics › Impurities & related substances · 4 Feb 2026 · 1 like On post #77 — agreed on the reasoning, with one qualification. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common…
-
Waist circumference technique and its repeatability Replied, post #45 · Outcomes › Progress reports · 30 Jan 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Reading a home test result without over-claiming — what changed since Started this topic · Analytics › Home & field testing · 26 Jan 2026 · 26 likes On the subject in the title: Reading a home test result without over-claiming — what changed since Working notes rather than a conclusion. Working through the identity…
-
Reading an interaction checker output critically Replied, post #73 · Practice › Interactions · 23 Dec 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #20 · Compounds › Retatrutide · 1 Dec 2025 · 9 likes post #19 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Reading SURMOUNT-1 without the press release Replied, post #78 · Compounds › Tirzepatide · 25 Nov 2025 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #43 · Sourcing › Regulatory · 22 Nov 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Availability by country, dated, with primary sources Replied, post #66 · Access › International · 19 Nov 2025 · 16 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #26 · Start Here › How to Ask · 25 Oct 2025 · 26 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #8 · Start Here › How to Ask · 18 Oct 2025 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
When to stop reading forums, including this one Replied, post #33 · Wellbeing › Mental health · 5 Oct 2025 · 10 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Payment method and the leverage it gives you, ranked Replied, post #64 · Sourcing › Payments · 23 Sep 2025 · 30 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #34 · Compounds › Oral incretins · 3 Sep 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #21 · Practice › Storage & stability · 6 Aug 2025 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 6 Aug 2025 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
A ten-fold dose error caught before injection — one year on Replied, post #148 · Devices › Syringes & needles · 5 Aug 2025 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #23 · Compounds › Secretagogues & GH axis · 30 Jul 2025 · 2 likes On post #19 — agreed on the reasoning, with one qualification. Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large…
-
About the Administration category Replied, post #6 · Practice › Administration · 22 Jul 2025 · 5 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Cagrilintide molecular characteristics and analytical considerations Started this topic · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 43 likes Cagrilintide molecular characteristics and analytical considerations — setting out what I have, and where I think it stops being reliable. I have seen SURMOUNT-2 (…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #65 · Evidence › Journal club · 6 Jul 2025 · 1 like Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #19 · Data & Tools › Datasets · 30 Jun 2025 · 14 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #70 · Compounds › Retatrutide · 16 Jun 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pre-registering a personal experiment, seriously Replied, post #58 · Research Methods › N-of-1 designs · 30 May 2025 · 3 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 28 May 2025 · 28 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Half-life, steady state, and accumulation worked through Replied, post #32 · Pharmacology › Pharmacokinetics · 28 May 2025 · 6 likes I read post #30 twice before replying, because I had assumed the opposite. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the…
-
A report I filed that turned out to be wrong, and the correction Replied, post #66 · Sourcing › Vendor reports · 23 May 2025 · 4 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Requesting a page: what makes a good request Replied, post #72 · Documentation › Wiki requests · 26 Apr 2025 · 7 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Carryover and the ghost peak from last week's standard Replied, post #68 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 20 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #86 · Access › International · 8 Mar 2025 · 28 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #20 · Practice › Reconstitution · 8 Mar 2025 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Regression to the mean in progress reports Replied, post #61 · Research Methods › Statistics · 19 Feb 2025 · 7 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Checking someone else's arithmetic: a worked example thread Replied, post #23 · Practice › Reconstitution · 19 Feb 2025 · 28 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
A page that has drifted out of date and needs a maintainer Replied, post #63 · Documentation › Wiki requests · 12 Feb 2025 · 25 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #64 · Evidence › Meta-analyses · 6 Feb 2025 · 32 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What changed in 2026, by region Replied, post #102 · Access › International · 26 Jan 2025 · 1 like Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Protein density versus volume when you cannot eat much Replied, post #22 · Nutrition & Training › Protein & intake · 26 Jan 2025 · 1 like Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Criticising the method without criticising the authors Replied, post #34 · Evidence › Study critique · 24 Jan 2025 · 0 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #7 · Compounds › Retatrutide · 20 Jan 2025 · 0 likes This follows post #4 rather than contradicting it. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for…
-
Telehealth prescribing models in the US Replied, post #43 · Regional › North America · 8 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #98 · Access › Insurance & coverage · 1 Jan 2025 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Coming back to: When to suspect the method rather than the sample Replied, post #123 · Analytics › Method validation · 24 Dec 2024 · 24 likes post #122 answers the question as asked. The question underneath it is different. System suitability: injections run at the start of a batch to establish that the…
-
Building a sensible monitoring schedule with your prescriber Replied, post #97 · Clinical › Bloodwork · 22 Dec 2024 · 14 likes post #96 answers the question as asked. The question underneath it is different. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading…
-
Building a sensible monitoring schedule with your prescriber Replied, post #72 · Clinical › Bloodwork · 21 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Body image changing more slowly than the body Replied, post #43 · Wellbeing › Mental health · 15 Dec 2024 · 27 likes Coming back to post #41, because the follow-up matters more than the original answer. When to involve a professional: if mood changes are persistent, deepen over weeks,…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #16 · Evidence › Journal club · 19 Nov 2024 · 0 likes On post #12 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
-
Here for the analytics and not much else — one year on Replied, post #5 · Lounge › Introductions · 16 Nov 2024 · 2 likes Picking up post #2: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Gallbladder disease risk with rapid weight loss Replied, post #31 · Clinical › Comorbidities · 15 Nov 2024 · 10 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Asking about a compound your prescriber has not heard of — one year on Replied, post #3 · marked as the solution · Clinical › Prescriber conversations · 12 Nov 2024 · 9 likes post #2 is right about the mechanism and I think understates the practical bit. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #53 · Compounds › Tirzepatide · 10 Nov 2024 · 7 likes post #52 is right about the mechanism and I think understates the practical bit. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
Time to steady state after a dose increase Replied, post #157 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Irish differences from the UK position Replied, post #28 · Regional › UK & Ireland · 9 Oct 2024 · 3 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #9 · Wellbeing › Mental health · 29 Sep 2024 · 11 likes Coming back to post #7, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Transit times by route, from a logged dataset — the long version Replied, post #14 · Sourcing › Logistics · 21 Sep 2024 · 2 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #31 · Analytics › Method validation · 11 Sep 2024 · 9 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Blind submission and why it changes minds Replied, post #29 · Sourcing › Independent verification · 5 Aug 2024 · 7 likes Coming back to post #27, because the follow-up matters more than the original answer. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork…